Fatal bleeding is rare with extended dual antiplatelet therapy, according to a secondary analysis of the DAPT Study. Bleeding-related mortality accounted for a minority of deaths in patients treated with dual antiplatelet therapy beyond one year.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1VrX1MF
No comments:
Post a Comment